STOCK TITAN

[Form 4] Penumbra Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Penumbra (PEN) director Harpreet Grewal reported a sale of common stock. On 10/02/2025, the reporting person sold 186 shares at $248.61 per share under a Rule 10b5-1 trading plan. Following the transaction, the filer directly beneficially owned 8,702 shares. A portion of these shares is subject to vesting.

Penumbra (PEN) il direttore Harpreet Grewal ha riportato una vendita di azioni ordinarie. Il 10/02/2025, la persona che segnala ha venduto 186 azioni al prezzo di $248,61 per azione nell’ambito di un piano di trading Rule 10b5-1. A seguito della transazione, il dichiarante deteneva direttamente 8.702 azioni. Una parte di queste azioni è soggetta a vesting.

Penumbra (PEN) el director Harpreet Grewal informó la venta de acciones comunes. El 10/02/2025, la persona que reporta vendió 186 acciones a un precio de $248,61 por acción bajo un plan de trading Rule 10b5-1. Tras la transacción, el informante poseía directamente 8.702 acciones. Una parte de estas acciones está sujeta a vesting.

Penumbra (PEN) 이사 Harpreet Grewal가 보통주 매도를 보고했습니다. 2025년 10월 2일에 보고자은 186주$248.61달러에 매도했으며 Rule 10b5-1 거래 계획에 따라 이루어졌습니다. 거래 후 발신자는 직접적으로 8,702주를 보유하게 되었습니다. 이 중 일부 주식은 vesting 대상입니다.

Penumbra (PEN) le directeur Harpreet Grewal a annoncé la vente d’actions ordinaires. Le 10/02/2025, la personne qui déclare a vendu 186 actions au prix de $248,61 par action dans le cadre d’un plan de négociation Rule 10b5-1. Suite à la transaction, le déclarant détenait directement 8.702 actions. Une partie de ces actions est soumise à vesting.

Penumbra (PEN) Direktor Harpreet Grewal meldete den Verkauf von Stammaktien. Am 02.10.2025 verkaufte die meldepflichtige Person 186 Aktien zu einem Kurs von $248,61 pro Aktie im Rahmen eines Rule-10b5-1-Handelsplans. Nach der Transaktion besaß der Offenleger direkt 8.702 Aktien. Ein Teil dieser Aktien unterliegt Vesting.

Penumbra (PEN) مديرها Harpreet Grewal أبلغ عن بيع أسهم عادية. في 10/02/2025، قامت الشخص المبلغ عنه ببيع 186 سهماً بسعر $248.61 للسهم بموجب خطة التداول Rule 10b5-1. بعد الصفقة، امتلك المصرح له بشكل مباشر 8,702 أسهم. جزء من هذه الأسهم خاضع لعملية vesting.

Penumbra (PEN) 董事 Harpreet Grewal 报告出售普通股。于 2025/10/02,报告人以每股 $248.61 的价格在 Rule 10b5-1 交易计划下出售了 186 股。交易完成后,该申报人直接受益持有 8,702 股。其中一部分股票处于归属期 vesting。

Positive
  • None.
Negative
  • None.

Penumbra (PEN) il direttore Harpreet Grewal ha riportato una vendita di azioni ordinarie. Il 10/02/2025, la persona che segnala ha venduto 186 azioni al prezzo di $248,61 per azione nell’ambito di un piano di trading Rule 10b5-1. A seguito della transazione, il dichiarante deteneva direttamente 8.702 azioni. Una parte di queste azioni è soggetta a vesting.

Penumbra (PEN) el director Harpreet Grewal informó la venta de acciones comunes. El 10/02/2025, la persona que reporta vendió 186 acciones a un precio de $248,61 por acción bajo un plan de trading Rule 10b5-1. Tras la transacción, el informante poseía directamente 8.702 acciones. Una parte de estas acciones está sujeta a vesting.

Penumbra (PEN) 이사 Harpreet Grewal가 보통주 매도를 보고했습니다. 2025년 10월 2일에 보고자은 186주$248.61달러에 매도했으며 Rule 10b5-1 거래 계획에 따라 이루어졌습니다. 거래 후 발신자는 직접적으로 8,702주를 보유하게 되었습니다. 이 중 일부 주식은 vesting 대상입니다.

Penumbra (PEN) le directeur Harpreet Grewal a annoncé la vente d’actions ordinaires. Le 10/02/2025, la personne qui déclare a vendu 186 actions au prix de $248,61 par action dans le cadre d’un plan de négociation Rule 10b5-1. Suite à la transaction, le déclarant détenait directement 8.702 actions. Une partie de ces actions est soumise à vesting.

Penumbra (PEN) Direktor Harpreet Grewal meldete den Verkauf von Stammaktien. Am 02.10.2025 verkaufte die meldepflichtige Person 186 Aktien zu einem Kurs von $248,61 pro Aktie im Rahmen eines Rule-10b5-1-Handelsplans. Nach der Transaktion besaß der Offenleger direkt 8.702 Aktien. Ein Teil dieser Aktien unterliegt Vesting.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Grewal Harpreet

(Last) (First) (Middle)
ONE PENUMBRA PLACE

(Street)
ALAMEDA CA 94502

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Penumbra Inc [ PEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 S(1) 186 D $248.61 8,702(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
2. A portion of these shares is subject to vesting.
Remarks:
/s/ Johanna Roberts, as attorney-in-fact for Harpreet Grewal 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

10.16B
37.51M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA